4//SEC Filing
Redmond Precillia 4
Accession 0001213900-21-011690
CIK 0001816736other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:52 PM ET
Size
5.7 KB
Accession
0001213900-21-011690
Insider Transaction Report
Form 4
Redmond Precillia
Chief People Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-23+25,489→ 25,489 totalExercise: $14.21Exp: 2031-02-22→ Common Stock (25,489 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, February 23, 2021 with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001843163
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:52 PM ET
- Size
- 5.7 KB